Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 106Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 15GlaxoSmithKline Inc.

02 5Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Lamivudine

Brand Name : 3TC

Patent Number : 2059263

Filing Date : 1991-05-02

Strength per Unit : 10mg / ml

Dosage Form : Oral Solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-05-02

Date Granted : 2001-04-10

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Lamivudine

Brand Name : 3TC

Patent Number : 2286126

Filing Date : 1998-03-20

Strength per Unit : 10mg / ml

Dosage Form : Oral Solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-20

Date Granted : 2003-08-12

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Lamivudine

Brand Name : 3TC

Patent Number : 2216634

Filing Date : 1996-03-28

Strength per Unit : 10mg / ml

Dosage Form : Oral Solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-03-28

Date Granted : 2004-07-20

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Lamivudine

Brand Name : 3TC

Patent Number : 2059263

Filing Date : 1991-05-02

Strength per Unit : 150mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-05-02

Date Granted : 2001-04-10

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Lamivudine

Brand Name : 3TC

Patent Number : 2216634

Filing Date : 1996-03-28

Strength per Unit : 150mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-03-28

Date Granted : 2004-07-20

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Lamivudine

Brand Name : HEPTOVIR

Patent Number : 2100269

Filing Date : 1992-01-03

Strength per Unit : 100mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-03

Date Granted : 1999-02-23

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Lamivudine

Brand Name : HEPTOVIR

Patent Number : 2216634

Filing Date : 1996-03-28

Strength per Unit : 100mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-03-28

Date Granted : 2004-07-20

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Lamivudine

Brand Name : HEPTOVIR

Patent Number : 2100269

Filing Date : 1992-01-03

Strength per Unit : 5mg / ml

Dosage Form : Oral Solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-03

Date Granted : 1999-02-23

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Lamivudine

Brand Name : HEPTOVIR

Patent Number : 2216634

Filing Date : 1996-03-28

Strength per Unit : 5mg / ml

Dosage Form : Oral Solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-03-28

Date Granted : 2004-07-20

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Lamivudine

Brand Name : 3TC

Patent Number : 2059263

Filing Date : 1991-05-02

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-05-02

Date Granted : 2001-04-10

blank